generic glp-1 cost Lifetime Social Returns From Expanding Access to Anti-Obesity Medications - March 27, 2025 The GLP-1 shortage is real.

Description

Integrative methods provide diverse tools for immediate relief, while functional principles ensure long-term solutions

Procedures such as gastric bypass and duodenal switch often produce the largest weight loss outcomes, although results still vary between individuals

Side Effects Both medications share a similar side effect profile that reflects their shared GLP-1 mechanism

A large retrospective cohort study revealed that T2DM patients treated with GLP-1RAs exhibited a significantly reduced risk of developing dementia compared with those receiving other glucose-lowering therapies.126 In a clinical trial involving cognitively intact individuals aged 4570 years at risk for AD, liraglutide administration for 12 weeks enhanced intrinsic connectivity within the default mode network as measured by resting-state functional magnetic resonance imaging, although no significant cognitive improvements were observed during the study period.127 In patients with mild cognitive impairment and AD, an 18-month course of exenatide was well tolerated but did not yield significant changes in clinical or cognitive outcomes or in most neuroimaging or biomarker assessments, except for a reduction in plasma neuronal extracellular vesicle A42 levels, potentially reflecting systemic neuronal status

The 2023 phase 2 double-blind, randomized controlled trial evaluating a GLP-1/GIP/glucagon receptor triagonist (retatrutide) in patients with the disease of obesity reported 24.2% weight loss at 48 weeks with 12 mg retatrutide